Delcath Systems (DCTH)
(Delayed Data from NSDQ)
$4.70 USD
+0.22 (4.92%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $4.70 +0.01 (0.11%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Price, Consensus and EPS Surprise
DCTH 4.70 +0.22(4.92%)
Will DCTH be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DCTH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DCTH
Can Delcath Systems (DCTH) Climb 277.73% to Reach the Level Wall Street Analysts Expect?
Delcath Systems (DCTH) Upgraded to Buy: What Does It Mean for the Stock?
DCTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Delcath Systems, Inc. (DCTH) Reports Q4 Loss, Tops Revenue Estimates
DexCom (DXCM) Soars 9.8%: Is Further Upside Left in the Stock?
Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates
Other News for DCTH
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH), Zevra Therapeutics (ZVRA) and Corcept Therapeutics (CORT)
Wall Street Analysts Are Bullish on Top Healthcare Picks
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Aerovate Therapeutics (AVTE) and Delcath Systems (DCTH)